PRAME and hematopoietic and lymphoid cell neoplasm: Recently, a computational transmembrane analysis predicted an extracellular region of the PRAME protein that could be specifically targeted by a conventional PRAME-specific antibody on multiple solid and hematological cancer cell lines in vitro and in vivo, thereby presenting new opportunities for additional CAR strategies targeting this protein (38).